Literature DB >> 23479685

A decade of the Common Drug Review.

Sarah Spitz.   

Abstract

Mesh：

Year:  2013        PMID： 23479685      PMCID： PMC3626820          DOI： 10.1503/cmaj.109-4428

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

Review 1.  Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

Authors:  Devidas Menon; Derek Clark; Tania Stafinski
Journal:  Healthc Policy       Date:  2015-08

2.  Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study.

Authors:  Nicola Allen; Stuart R Walker; Lawrence Liberti; Chander Sehgal; M Sam Salek
Journal:  CMAJ Open       Date:  2016-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.